Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-783 plus methotrexate versus placebo plus methotrexate in rheumatoid arthritis
2006-003054-26Phase 2Completed
- Sponsor
- Takeda
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing TAK-783 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Composite ACR20 response rate at Week 12. Started Aug 2007; status: completed.
02
Drugs
TAK-783
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-003054-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003054-26.